Maple Treat Xtreme Arth Forte
Natural health product licensed in Canada
- Licence holder
- Aurora Biotechnology Canada Inc
- NPN or DIN-HM
- 80068440
- Status
- Active licence
- Licence date
- 12 April 2016
- Revision date
- 23 March 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 300 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 25 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 200 milligramme | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 200 milligramme | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) | 100 milligramme | Not calculated |
| Salix alba Source : Jeune écorce de branche | 50 milligramme | Not calculated |
| Salix alba Source : Jeune écorce de branche Potency : 15 % Salicin | Not specified | Not calculated |
| Vitamine C Source : Acide ascorbique | 30 milligramme | 120,000 µg |
Non-medicinal ingredients
Cellulose, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve (joint) pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80068440
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging